Moorestown, New Jersey, United States
Thank You for visiting
about dan watson
about Dan Watson aka, danwatson888
about dan watson aka danwatson888
Thank you for visiting
Help with Your Diabetes Prescription and Insulin Costs
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)
- The Patient Assistance Program
The Lilly Diabetes Solution Center
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)
- Lilly Diabetes Solution Center Offers Insulin Affordability Assistance
The Novo Nordisk Patient Assistance Program (PAP)
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF)
- Patient Assistance Program
Accessing your medicines can be confusing. It doesn’t have to be.
PhRMA member companies are committed to helping patients make more informed health care decisions by providing more transparency about medicine costs. This, along with the development of the Medicine Assistance Tool, provides patients with the information they need to make more educated health care decisions.
PhRMA’s Medicine Assistance Tool (MAT) is a search engine designed to help patients, caregivers and health care providers learn more about the resources available through the various biopharmaceutical industry programs. MAT is not its own patient assistance program, but rather a search engine for many of the patient assistance resources that the biopharmaceutical industry offers.
Sanofi Patient Connection™
For U.S. Residents Only
Patient Connection Application
Help with Your Diabetes Prescription and Insulin Costs
Labiotech.eu’s Coverage of the Coronavirus
"We are building the Next Generation of Digital Media for Biotech" Philip, Joachim and Labiotech.eu
A Bioincubator is a launch-pad structure for entrepreneurs to make their project in the sciences real. In Europe, we have many incubators within each industry, responsible for strategic investment, development and providing a support network for start-ups.
Sectors: Pharmaceutical and Agricultural.
Sectors: Biotechnology
Sectors: Biotherapies, Genetics, Biotechnology
Sectors: Immuno-Oncology
Sectors: Life Sciences
Sectors: Agrifood, Bioeconomy and Life Sciences
Sectors: Biotechnology and Health
Sectors: Healthcare and Pharmaceuticals
Bioincubator
Finally, this short list shows you that Europe count a lot of great bioincubators. This means european Bio-entrepreneurs can find ideal places to start their business, from Sweden to Spain.
From prison to park: Camden's Cooper's Poynt Phaedra Trethan
A Prison Falls, a Playground Rises in North Camden By Matt Skoufalos | June 5, 2017
Overhauling the site was a project that took decades and millions of dollars. The Delaware River Port Authority allocated $8 million for demolition of the prison, and the New Jersey Economic Development Authority (EDA) supplemented that with $5 million in planning and infrastructure grants.
The Wells Fargo Regional Foundation kicked in $750,000 for a neighborhood planning grant, and the William Penn Foundation added another quarter-million dollars for the bikeway improvements.
There are plans to construct a mixed-use commercial-residential development on the surrounding property at Cooper’s Poynt, but the EDA still hasn’t found qualified developers to take on the project.
Maureen Hassett, EDA senior vice president of governance, communications, and strategic initiatives, said the agency is evaluating options for the land, which is still owned by the New Jersey Department of Corrections.
Rodney Sadler, Executive Director of the Save Our Waterfront neighborhood coalition, recollected the years of work that went into salvaging the property, from opposing construction of the prison to the day it was leveled.
“It made a difference,” Sadler said. “It made it possible.”
A Prison Falls, a Playground Rises in North Camden
Cooper’s Poynt Playground. Credit: Matt Skoufalos.
“There needs to be that other connection,” Sadler said. “It has to start somewhere.”